Jury Recommends Nearly $45 Million in Damages in False Advertising Case

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Jury Recommends Nearly $45 Million in Damages in False Advertising Case

J.W. Schomisch

March 17, 2022 at 04:50 PM EST

A jury March 14 recommended the award of nearly $45 million in damages in a false advertising case. In the trial in U.S. District Court for the District of Delaware between CareDx Inc. and Natera Inc. the jury found that both companies engaged in false advertising but that the preponderance of evidence was against Natera. The jury recommended awarding CareDx $21.2 million in ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Jury Recommends Nearly $45 Million in Damages in False Advertising Case

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT